Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux to Distribute AdvanDx's Bacteria Dx in the US

NEW YORK (GenomeWeb News) — BioMérieux will exclusively distribute AdvanDx’s diagnostic tests in the US, the French company said Tuesday. 
 
The tests, which use in situ hybridization technology, may be used to identify Staphylococcus aureus, Candida albicans, Enterococcus faecalis and other species of bacteria in fewer than five hours, the companies said.
 
BioMérieux said the diagnostic will allow doctors to make swifter diagnoses to improve management of antibiotics, improve care, and lower costs of blood infections.
 
Financial terms of the agreement were not released.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.